法国制药巨头赛诺菲（SNY）今日盘前大跌5.20%，主要原因是公司公布的第二季度业绩未能完全满足市场预期。
根据赛诺菲发布的财报，公司第二季度列账销售额为99.94亿欧元，符合市场预期，同比增长6%，以固定汇率计算则增长10.1%。然而，撇除单次项目后的季度业务经营溢利为24.61亿欧元，低于分析师预期的25.7亿欧元。赛诺菲解释称，研发成本上升以及与合作伙伴再生元制药的更高利润分享是导致季度利润不及预期的主要原因。
尽管如此，赛诺菲仍然上调了全年销售指引，预计销售将实现高单位数增长，这主要得益于其王牌消炎药Dupixent、疫苗及新疗法的强劲需求。公司同时确认了今年纯利将有低双位数增长的预测，但指出这一预测已经计及了新收购业务的所有开支。投资者似乎对赛诺菲的盈利能力表示担忧，导致股价在盘前交易中大幅下跌。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.